Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference
June 16, 2022 16:30 ET
|
Profound Medical Corp.
TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the 2022 Jefferies Global Healthcare Conference
June 02, 2022 16:30 ET
|
Profound Medical Corp.
TORONTO, June 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Annual and Special Meeting of Shareholders Voting Results
May 18, 2022 17:43 ET
|
Profound Medical Corp.
TORONTO, May 18, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual and Special Meeting...
Profound Medical Clarifies Recent Insider Buying
May 18, 2022 16:30 ET
|
Profound Medical Corp.
TORONTO, May 18, 2022 (GLOBE NEWSWIRE) -- In response to investor inquiries regarding insider trading activity, particularly with respect to recent open market stock purchases made by certain of its...
TULSA-PRO® Was Front and Center at AUA2022
May 17, 2022 17:25 ET
|
Profound Medical Corp.
TORONTO, May 17, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces First Quarter 2022 Financial Results
May 09, 2022 16:05 ET
|
Profound Medical Corp.
TORONTO, May 09, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference
April 25, 2022 16:30 ET
|
Profound Medical Corp.
TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release First Quarter 2022 Financial Results on May 9 – Conference Call to Follow
April 18, 2022 16:30 ET
|
Profound Medical Corp.
TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Fourth Quarter and Full Year 2021 Financial Results
March 03, 2022 16:03 ET
|
Profound Medical Corp.
TORONTO, March 03, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in March Investor Conferences
March 02, 2022 08:00 ET
|
Profound Medical Corp.
TORONTO, March 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...